Gunnar Telhammar
Director of Finance/CFO chez XINTELA AB
Profil
Gunnar Telhammar is currently the Chief Executive Officer & Director at BioFinans AB, Chief Financial Officer at LifeAssays AB, SensoDetect AB, AcouSort AB, Xintela AB, ImmuneBiotech Medical Sweden AB, Targinta AB, and Tendo AB.
He previously held positions as the Chief Financial Officer & Controller at Guard Therapeutics International AB, Chief Financial Officer at Preelumina Diagnostics AB, BiBBInstruments AB, and AegirBio AB.
He also worked as a Financial Manager at Telepartner AS (Norway) from 1990 to 1996.
Mr. Telhammar graduated from the University of Lund in 1990.
Postes actifs de Gunnar Telhammar
| Sociétés | Poste | Début |
|---|---|---|
| XINTELA AB | Director of Finance/CFO | 01/01/2013 |
| ACOUSORT AB | Director of Finance/CFO | 01/01/2016 |
| LIFEASSAYS AB (PUBL) | Director of Finance/CFO | - |
| TENDO AB | Director of Finance/CFO | - |
| SENSODETECT AKTIEBOLAG | Director of Finance/CFO | - |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Director of Finance/CFO | - |
| BioFinans AB | Chief Executive Officer | 01/01/2004 |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Director of Finance/CFO | 01/01/2019 |
Anciens postes connus de Gunnar Telhammar
| Sociétés | Poste | Fin |
|---|---|---|
| Telepartner AS (Norway) | Director of Finance/CFO | 01/01/1996 |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
Formation de Gunnar Telhammar
| University of Lund | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| SENSODETECT AKTIEBOLAG | Commercial Services |
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| ACOUSORT AB | Distribution Services |
| XINTELA AB | Health Technology |
| BIBBINSTRUMENTS AB | Health Technology |
| AEGIRBIO AB | Health Technology |
| TENDO AB | Health Technology |
| Entreprise privées | 6 |
|---|---|
LifeAssays AB
 LifeAssays AB Medical SpecialtiesHealth Technology LifeAssays AB is a diagnostic company, which engages in the provision of point-of-care diagnostic testing for veterinarians, community health centers and primary physicians. It's products include own produced instruments and disposable agents as well as blood analysis systems LifeAssays Reader and LifeAssays VetReader. The company was founded on August 17, 2000 and is headquartered in Lund, Sweden. | Health Technology |
| Preelumina Diagnostics AB | |
ImmuneBiotech Medical Sweden AB
ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Health Technology |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Health Technology |
| BioFinans AB | |
| Telepartner AS (Norway) |
